Basit öğe kaydını göster

dc.contributor.authorKaradağ, ŞG
dc.contributor.authorAyaz, Nuray
dc.contributor.authorTanatar, Ayşe
dc.contributor.authorÇakan, M
dc.date.accessioned2021-03-04T14:02:15Z
dc.date.available2021-03-04T14:02:15Z
dc.identifier.citationÇakan M., Karadağ Ş., Tanatar A., Ayaz N., "The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis", MODERN RHEUMATOLOGY, 2019
dc.identifier.issn1439-7595
dc.identifier.othervv_1032021
dc.identifier.otherav_7f74bdb4-2de5-4fe1-aeb1-282efde3e1f8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/86982
dc.identifier.urihttps://doi.org/10.1080/14397595.2019.1660026
dc.description.abstractObjectives: The aim of this study was to demonstrate the frequency of macrophage activation syndrome (MAS) in systemic juvenile idiopathic arthritis (sJIA) cases, to compare the laboratory tests at the time of diagnosis of sJIA and MAS and to see whether sJIA cases complicated with MAS follow a more severe disease course in the long-term follow-up. Methods: Files of children with sJIA that were followed between May 2010 and September 2017 were reviewed. Results: The cohort consisted of 53 sJIA cases. Mean duration of follow-up was 39.0 +/- 24.1 months. The frequency of MAS was 33.9%. Initial laboratory tests at the time of diagnosis of sJIA were compared in between patients with MAS and without MAS. Only ferritin and fibrinogen levels showed significant differences in between the groups (p < .01). Patients who developed MAS had higher ferritin (4482 mg/dL) and lower fibrinogen (371 mg/dL) values than patients without MAS (ferritin 2060 mg/dL, fibrinogen 466 mg/dL) at the time of diagnosis of sJIA. Long-term follow-up results showed that monocyclic course was observed in 45.2%, polycyclic course in 30.1% and persistent course in 24.5% of the cases. It was seen that patients with MAS segregated equally into three groups. Conclusions: Higher ferritin and relatively lower fibrinogen levels at the time of diagnosis of sJIA may be early warning signs of an impending MAS. sJIA patients who develop MAS do not seem to warrant more guarded prognosis in the long-term follow-up.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleThe frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis
dc.typeMakale
dc.relation.journalMODERN RHEUMATOLOGY
dc.contributor.department, ,
dc.contributor.firstauthorID837905


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster